VSee Health, Inc. (VSEE) — Financial statements
Income statement, balance sheet, and cash flow for VSee Health, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 15↑40.3% | 10↑80.7% | 6↓9.6% | 6↓13.1% | 7 | |
| Cost of Revenue | 7↑123.9% | 3↑67.8% | 2↑25.3% | 2↑9.1% | 1 | |
| Gross Profit | 7↑2.5% | 7↑87.3% | 4↓20.7% | 5↓18.4% | 6 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 17↑163.0% | 6↑795.7% | 0.72↓30.0% | 1↓81.9% | 6 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 5↑16.3% | 5↓11.6% | 5↑197.8% | -5 | |
| SG&A Expenses | 17↑42.8% | 12↑120.5% | 5↓14.6% | 6↑2128.4% | 0.28 | |
| Other Expenses | 0.00↓100.0% | 57↑17493.7% | 0.33↑51.2% | 0.22↓96.0% | 5 | |
| Operating Expenses | 17↓75.6% | 69↑1114.9% | 6↓12.4% | 7↑14.9% | 6 | |
| Total Costs & Expenses | 24↓66.7% | 73↑850.0% | 8↓5.2% | 8↑13.7% | 7 | |
| Operating Results | ||||||
| Operating Income | -10↑84.6% | -62↓3217.2% | -2↓11.5% | -2↓765.9% | 0.25 | |
| Depreciation & Amortization | 3↑100.5% | 1↑195101.6% | 0.00↓100.0% | 1↑680.3% | -0.25 | |
| EBITDA | -9↓173.2% | -3↓88.1% | -2 | 0.00 | 0.00 | |
| EBIT | -12↓152.7% | -5↓162.1% | -2↓22.0% | -1↓680.3% | 0.25 | |
| Interest & Other Income | ||||||
| Net Interest Income | -3↓1229.7% | -0.21↑88.4% | -2↓328.4% | 0.80↑40339.8% | 0.00 | |
| Interest Income | 0.00 | 0.00↓100.0% | 0.36↓61.1% | 0.92↑46734.7% | 0.00 | |
| Interest Expense | 3↑1229.7% | 0.21↓90.3% | 2↑1629.1% | 0.13 | 0.00 | |
| Non-Operating Income | 2↑103.9% | -57↓66108.1% | -0.09↑59.8% | -0.22 | 0.00 | |
| Other Income / Expenses | -5↓280.4% | 3↑21078.9% | -0.01↓122.3% | 0.06↓55.3% | 0.13 | |
| Income Before Tax | -15↑75.3% | -59↓3045.0% | -2↓16.5% | -2↓519.3% | 0.39 | |
| Income Tax Expense | 0.07↑104.2% | -2↓189.4% | 2↑364.8% | -0.69↓742.3% | 0.11 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -15↑74.5% | -58↓1448.9% | -4↓302.4% | -0.93↓432.7% | 0.28 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -15↑74.5% | -58↓1433.4% | -4↓350.0% | -0.84↓275.7% | 0.48 | |
| Bottom-Line Net Income | -15↑74.5% | -58↓1433.4% | -4↓350.0% | -0.84↓275.7% | 0.48 | |
| EPS (Basic) | -0.73↑87.1% | -5.65↓1386.8% | -0.38↓354.5% | -0.08↓274.9% | 0.05 | |
| EPS (Diluted) | -0.73↑87.1% | -5.65↓1386.8% | -0.38↓354.5% | -0.08↓274.9% | 0.05 | |
| Weighted Average Shares | 20↑97.2% | 10↑2.1% | 10↓0.0% | 10↑0.5% | 10 | |
| Weighted Average Diluted Shares | 20↑97.2% | 10↑2.1% | 10↑0.0% | 10↑0.5% | 10 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.